NEW YORK (GenomeWeb News) – Healthcare supply company Broadlane will sell Cepheid’s molecular diagnostics instruments, reagents, and services to its customers, which include more than 20,000 healthcare facilities in the US, Cepheid said today. 

 

Broadlane’s client base includes acute care hospitals, ambulatory care facilities, and physician’s offices, Cepheid said.